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The minus DNA strand of HIV-1 presents an open reading frame that is complementary to the HIV-1 envelope messenger,
is highly conserved among HIV-1 isolates, and may encode a hydrophobic protein. In previous studies, the antisense
transcript has been identified both in various HIV-infected cell lines and in leukocytes of HIV-11 patients. The expression of
the corresponding antisense protein (ASP) during natural HIV-1 infection has been indirectly evidenced by the identification
of anti-ASP antibodies in the sera of HIV1 patients. We have used immunoelectron microscopy procedures (ultrasmall gold
particles coupled to silver enhancement) to establish direct evidence of ASP production. ASP has then been detected in
chronically and acutely HIV-1-infected cell lines. The protein, found mostly associated with various cellular membranes as
well as with the virions released from the cells, indicated that ASP is a bona fide component for the virions and may
participate in the particle formation. © 2002 Elsevier ScienceKey Words: endogenous; natural; antisense protein; HIV-1; immunoelectron microscopy; silver–gold enhancement; ultra-
small gold particles.INTRODUCTION
An increasing number of reports have described the
existence of naturally occurring antisense transcripts in
eukaryotes, suggesting that the generation of such tran-
scripts constitutes a general mechanism for the control
of gene regulation, as has been established for pro-
karyotes (Wagner and Simons, 1994). Numerous exam-
ples of transcripts complementary to messenger RNAs
of known function have been identified, and many such
transcripts have been proposed to modulate expression
of their sense counterparts at different levels ranging
from DNA to protein expression, sometimes leading to
various pathologies (for review see Vanhe´e-Brossollet
and Vaquero, 1998; Kumar and Carmichael, 1998). In
addition, some of these transcripts appeared to be po-
tential templates for proteins, although as yet such pro-
teins have proven difficult to characterize (Kimelman and
Kirschner, 1989; Lagunoff and Roizman, 1994; Li et al.,
1996).
Some years ago, computer analysis of 12 HIV-1 iso-
lates revealed an open reading frame (ORF) on the neg-
ative strand of the HIV-1 sequence, in a region comple-
mentary to the env gene sequence (Miller, 1988). We and
others (Michael et al., 1994; Vanhe´e-Brossollet et al.,
1995) have reported the existence of a natural transcript
complementary to the env sequence in diverse cellular
contexts. This antisense transcript was detected in var-
ious cell lines infected chronically or productively with1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 133 1 45 83 88 58. E-mail: vaquero@ext.jussieu.fr.
177laboratory-adapted HIV-1 isolates, as well as in T cells of
patients infected with various primary isolates (Michael
et al., 1994; and our unpublished results). In agreement
with these observations, transcription has been shown
to be initiated from the 39 LTR, albeit with a lower effi-
ciency than from its 59 LTR counterpart, and has given
rise to the expected antisense transcript. Positive-sense
RNA expression and negative-sense RNA expression do
not appear to be subjected to the same regulatory sig-
nals, since a different array of cis-acting elements comes
into play (Michael et al., 1994; Peeters et al., 1996) upon
activation/initiation of transcription from the two HIV-1
LTRs. It has also been reported that ectopic expression
of the antisense HIV-1 RNA decreased the abundance of
the sense HIV-1 messenger counterparts and therefore
decreased the viral yield (Kim et al., 1996; Tagieva and
Vaquero, 1997).
The antisense transcript appeared to be a potential
template (Miller, 1988) for a highly hydrophobic ORF of
approximately 190 amino acids in length, judging from
the 12 HIV-1 isolates studied. We have provided indirect
evidence for the existence of this antisense protein (ASP)
by identifying, in sera of HIV-11 patients, antibodies di-
rected against the protein obtained through an in vitro
transcription and translation system (Vanhe´e-Brossollet
et al., 1995). ASP could not be detected unambiguously
after immunoprecipitation and Western blotting per-
formed with lysates of infected T cells or cells overex-
pressing ASP, although immunofluorescence analyses
performed with several antisera directed against the
antisense protein or an affixed tag were indicative of the
presence of the protein. In the present study, we report a
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178 BRIQUET AND VAQUEROcomputer analysis of the ASP present in the HIV-1BRU and
the successful use of immunogold labeling and electron
microscopy (EM) to detect the antisense protein and
define its subcellular localization in different types of
cells either overexpressing ASP or infected with two
different HIV-1 isolates.
RESULTS AND DISCUSSION
Computer analysis of the HIV-1 antisense proteins
An antisense transcript, complementary to the HIV-
1BRU env gene in a region encompassing the cleavage
site of the gp160 precursor, has been identified in in-
fected cells (Michael et al., 1994; Vanhe´e-Brossollet et
al., 1995). This transcript, moreover, appeared to encode
an antisense protein of 189 aa. In an attempt to deter-
mine whether such transcripts and their putative cognate
proteins were likely to be of general importance, we
performed computational analyses with a large number
of HIV sequences and found that the ASP sequence was
well conserved among up to 550 genomic and env HIV-1
sequences of laboratory-adapted and primary HIV-1 se-
quences listed in the nonredundant virus library of Gen-
Bank. The putative HIV-1BRU ASP protein (EMBL Acces-
sion No. AJ310535) was particularly rich in hydrophobic
amino acids (65%). Three transmembrane helices (10–26,
59–75, and 152–168) and a cytoplasmic N-terminus were
predicted according to the “psort II” program (nibb.ac,
Japan) indicating an association with cellular mem-
branes. Membrane association prediction was 22% for
both endoplasmic reticulum and plasma membrane and
17.5% for nuclear localization. ASP was also predicted to
associate, although at a lower level, with the cell wall,
mitochondria, cytoskeleton, Golgi, cytoplasm, peroxi-
somes, vacuoles, and vesicles of the secretary system.
In conclusion, numerous considerations, including the
identification of antisense transcripts in HIV-1-infected
cells, the high degree of conservation between HIV-1BRU
ASP and the antisense sequences encountered in a
large number of other HIV-1 isolates and even in several
SIV isolates, as well as the presence of an antisense
ORF and antisense transcripts in a nonprimate lentivirus,
FIV (Briquet et al., 2001), argue in favor of the antisense
transcript encoding a genuine antisense protein rather
than it being a computer analysis artifact. For this reason,
we used electron microscopy to confirm the expression
of ASP, previously suggested by the presence of ASP-
specific antibodies in the sera of HIV-11 patients (Van-
he´e-Brossollet et al., 1995), and to define its subcellular
localization in HIV-1-infected cells.
Localization of HIV-1 ASP in a T cell line
overexpressing the antisense proteinIn order to detect the protein, we derived several
reagents including ASP expression vectors and im-mune sera (see Materials and Methods). We first ex-
amined the presence of ASP in the A3.01 T cells stably
transformed with pL(VSV-AS)SN so as to overexpress
the tagged ASP protein. The expression of the anti-
sense messenger was verified by Northern blot (data
not shown). A3.01 vesicular stomatitis virus (VSV)–ASP
and A3.01 VSV control cells were analyzed by immu-
noelectron microscopy with either an anti-VSV Mab
(clone P5D4) or an anti-ASP antibody as the first an-
tibody, followed by secondary immunogold conju-
gates. The binding of P5D4 had been previously veri-
fied by immunoblot of a VSV fusion protein (data not
shown). Binding of the rabbit anti-ASP serum obtained
after immunization with three ASP peptides (1–10, 45–
60, and 174–189) was assessed by recognition up to
1:10,000 dilution of the recombinant GST–ASP fusion
protein (Fig. 1, lane 1) corresponding to a unique
46-kDa band (lane 3) also revealed by the anti-GST
antibody (lane 4). In contrast, no signal was detected
with the preimmune serum (lane 2).
Immunogold labeling of the A3.01 VSV–ASP cells
showed that ASP protein was recognized, albeit
weakly, by both anti-VSV Mab (Fig. 2b) and anti-ASP
antiserum (Fig. 2c). Interestingly, labeling was found
mostly associated with the cell inner membranes and
more particularly in the vicinity of mitochondria. Small
clusters of gold particles (10 nm) were observed on
both sides of cellular (Fig. 2c), nuclear (Figs. 2b and
2c), and mitochondrial (Fig. 2b) membranes. Two con-
trol experiments were performed either with A3.01 VSV
control cells incubated successively with primary and
secondary antibodies or with A3.01 VSV–ASP cells
incubated with the secondary antibody only (Fig. 2a).
We then analyzed two T lymphocyte cell lines chroni-
FIG. 1. Assessment of the anti-ASP serum. 100 ng of GST–ASP fusion
protein (46 kDa) produced in E. coli (lane 1) was analyzed by Western
blot performed with a 1:10,000 dilution of preimmune serum (lane 2),
with a 1:10,000 dilution of anti-ASP serum 73 days postimmunization
(lane 3), and with a 1:1000 dilution of anti-glutathione S-transferase
(rabbit IgG, Sigma, lane 4). Each reaction is revealed with a 1:10,000
dilution of anti-rabbit IgG peroxydase conjugate (Sigma). Prestained
molecular weight markers (Biolabs) are indicated on the left.cally or acutely infected with two different laboratory-
adapted HIV-1 isolates.
ugate.
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chronically infected with HIV-1BRU
The ACH-2 cell line was derived from cells surviving
acute infection of the A3.01 clone (a variant of the
CEM-T cell line) with HIV-1BRU. ACH-2 cells generated
a small number of viruses, if any, in the absence of
PMA, but upon activation by PMA (Serpente et al.,
1992) produced viral transcripts, proteins, and there-
after viruses. Detection of ASP was investigated in
these cells prior to and after 24 h of activation with
PMA. Ultrathin sections of cells were successively
incubated with the anti-ASP rabbit serum and then
either the goat anti-rabbit IgG (Figs. 3d and 3e) or the
F(ab9) goat anti-rabbit IgG (Figs. 3a, 3b, 3c, 3f, and 3g)
coupled to UltraSmall (US; #1 nm) gold particles. The
FIG. 2. Electron microscopy analysis of A3.01 VSV–ASP sections afte
grids were directly incubated with a 1:10 dilution of goat anti-rabbit IgG
of monoclonal anti-VSV glycoprotein (mouse IgG1, clone P5D4, purchas
further incubated with a 1:10 dilution of goat anti-mouse IgG gold conj
labeling.coupling of IgG and F(ab9) antibodies to US particles
reduced steric hindrance of the gold conjugates, in-creased its accessibility to the antisense protein
epitopes, and therefore enhanced the sensitivity of
detection. All grids were further subjected to a silver
enhancement reaction to increase the apparent parti-
cle size. Prior to activation, few single gold particles
could be detected (Fig. 3a) indicating expression of
ASP, in agreement with the low level of antisense
transcripts observed in ACH-2 cells (Vanhe´e-Bros-
sollet et al., 1995). After activation, clusters of a sig-
nificant number of gold particles were present in sev-
eral cell compartments and, in particular, in the close
vicinity of nuclear (Figs. 3d and 3f), nucleolar (Fig. 3e),
and mitochondrial membranes (Fig. 3g) in good corre-
lation with the enhancement of antisense RNA tran-
scripts (Vanhe´e-Brossollet et al., 1995). Moreover, a
nolabeling with the anti-VSV (P5D4) and anti-ASP sera. A3.01 VSV–ASP
njugate (10-nm particles, Sigma), as a negative control (a), with 5 mg/ml
Sigma) (b), or with 5 mg/ml of anti-ASP (c). Sections in (b) and (c) were
M, mitochondria; N, nucleus; scale bar, 200 nm. Arrows point out goldr immu
gold co
ed fromlow yield of viral particles was observed under these
conditions with some virions presenting a low accu-
180 BRIQUET AND VAQUEROmulation of gold particles (data not presented). The
two controls, incubated only with the F(ab9) goat anti-
rabbit gold conjugate, remained negative as shown in
FIG. 3. Electron microscopy analysis of HIV-1BRU chronically infe
Nonactivated ACH-2 grids were incubated with 5 mg/ml of anti-ASP and
(#1-nm particles, Aurion) gold conjugate (a) or with F(ab9) anti-rabbit Ig
anti-rabbit IgG US gold conjugate alone (c) or with 5 mg/ml of anti-ASP
(d and e) or a 1:100 dilution of the F(ab9) anti-rabbit IgG US gold conju
nucleolus; scale bar, 200 nm.nonactivated and activated ACH-2 cells (Figs. 3b and
3c).Localization of HIV-1 ASP in cells acutely infected
with HIV-1HXB2
CH-2 lymphocytes after immunolabeling with the anti-ASP serum.
1:100 dilution of the F(ab9) fragment of a goat anti-rabbit IgG ultrasmall
old conjugate alone (b). Activated ACH-2 cells were labeled with F(ab9)
and either a 1:100 dilution of a goat anti-rabbit IgG US gold conjugate
and g). All grids were subjected to silver enhancement. N, nucleus; n,cted A
with a
G US g
serum
gate (fThe SupT1 cells, which exhibit high levels of CD4, the
major viral receptor, were transfected with pHXB2-MCS
re sub
181ASP IN HIV-1 INFECTED CELLS AND VIRAL PARTICLES(gift of N. Michael), giving rise to acute HIV-1 infection
and a high yield of HIV-1HXB2 viruses. SupT1HXB2 cells were
analyzed with the anti-ASP serum and with F(ab9) goat
anti-rabbit ultrasmall gold particles after silver enhance-
ment. As shown in Fig. 3, clusters of gold particles
appeared to concentrate in the nucleus and in the cyto-
plasm (Figs. 4c and 4f). Labeling was also distinctly
present in association with viral particles released from
FIG. 4. Electron microscopy analysis of HIV-1HXB2 acutely infected Su
SupT1 cell grid was incubated with 5 mg/ml of anti-ASP and with a 1:1
Infected SupT1HXB2 grids were labeled with F(ab9) anti-rabbit IgG US gol
of F(ab9) anti-rabbit IgG US gold conjugate (c, d, e, and f). All grids we
nm.the cells. The virion morphology was round and of uni-
form size, approximately 100 nm, as expected in ultrathinsections of productive cells analyzed by electron immu-
nocytochemistry. Depending on the orientation of the
virions in the section, some rather electron-dense virions
appeared to be covered by gold particles (Figs. 4c, 4d,
and 4f), whereas less electron-dense particles with a
clearly delineated circular lipid outer membrane were
labeled just along their surface structure (Figs. 4d and
4e). Sections of noninfected SupT1 control cells incu-
phocytes after immunolabeling with the anti-ASP serum. Noninfected
tion of F(ab9) fragment of a goat anti-rabbit IgG US gold conjugate (a).
gate alone (b) or with 5 mg/ml of the anti-ASP serum and 1:100 dilution
jected to silver enhancement. N, nucleus; n, nucleolus; scale bar, 200pT1 lym
00 dilu
d conjubated successively with anti-ASP and with the secondary
US gold conjugate antibody (Fig. 4a) as well as sections
182 BRIQUET AND VAQUEROof infected SupT1HXB2 directly incubated with the US gold
conjugate (Fig. 4b) presented no background labeling.
In summary, the data presented show that tagged ASP
was produced in A3.01 cells after stable transfection with
the pL(VSV-AS)SN vector and could be identified not only
with a monoclonal antibody directed against the VSV
portion, but also with a polyclonal antibody directed
against the HIV-1 antisense protein. More interestingly,
the endogenous protein was produced in cell lines in-
fected with two different HIV-1 isolates, HIV-1BRU and
HIV-1HXB2. The combined use of US gold conjugates and
silver enhancement in order to reduce steric hindrance
and augment the number of antibody/gold entities parti-
cles bound per surface area proved essential to obtain
more readily interpretable levels of labeling. Indeed, im-
munogold–silver techniques using US conjugates had
been previously employed to label intracellular antigens
associated with microtubules, ribosomes, endoplasmic
reticulum, nuclear aggregates, etc. (Yi et al., 2001). The
labeling pattern of ASP was found in different cellular
compartments (cytoplasm and nucleus) principally in the
vicinity of the cell membranes (Figs. 3 and 4). This finding
is in agreement with the high degree of hydrophobicity
and the potential for three transmembrane domains, as
well as with the computer prediction of an intracellular
localization for ASP. Finally, in Sup T1 cells acutely in-
fected with HIV-1HXB2, the EM analyses revealed that ASP
is not only present in productively infected cells, but is
also retained in the mature viral particles released from
the cells. In addition, the virus yield determined by p24
analysis of a HIV-1HXB2 virus mutated in its capability to
produce ASP without affecting Env production is clearly
decreased when compared to that of the wild-type iso-
late (N. Michael, S.B., and C.V., personal communication).
All these considerations argue strongly in favor of ASP
participation in the replicative cycle of HIV-1. Antisense
transcripts and ASP might therefore be of general impor-
tance in the natural history of retroviruses and control the
production of viral particles.
MATERIALS AND METHODS
Antibodies
Primary antibodies used to characterize ASP protein
were as follows: anti-glutathione S-transferase (rabbit
IgG, Sigma) used to identify the GST–ASP fusion protein,
monoclonal anti-VSV glycoprotein (mouse IgG1, clone
P5D4, provided from Sigma) directed against the tag of
VSV–ASP, and a polyclonal antipeptide serum prepared
by CovalAb (University of Lyon-Sud, France) directed
against the antisense protein. For the latter antiserum, a
New Zealand rabbit was immunized with three peptides
(MPQTVSCNRC, residues 1–10; CLPAAPKNPRNKAPIP,
residues 45–60 corresponding to the major hydrophilic
domain; QVLLNQVLLNSCVELQ, residues 174–189) de-
rived from the ASP amino acid sequence of HIV-1BRU. Aserum showing a high level of anti-ASP activity was
obtained after the second booster inoculation (day 73)
and was thus selected for use in immunochemical anal-
yses. An anti-rabbit IgG peroxidase conjugate (Sigma)
was used to analyze ASP antiserum by Western blot.
Secondary antibodies used for immunogold reaction
were as follows: goat anti-mouse IgG, goat anti-rabbit
IgG gold conjugates (10-nm particles, Sigma), goat anti-
rabbit IgG Ultrasmall conjugate, and F(ab9) fragment of
goat anti-rabbit IgG Ultrasmall conjugate (#1-nm parti-
cles, Aurion).
Virus strains
Two different isolates of HIV-1, the HIV-1BRU isolate
(Wain-Hobson et al., 1985) and the HIV-1HXB2 molecular
clone (Ratner et al., 1985), were investigated.
Expression vectors
The pGEX-2T (Pharmacia) was used to express ASP in
Escherichia coli as a fusion protein of GST with anti-
sense HIV-1BRU ORF obtained by PCR from the vector
pEDH (Ellerbrok et al., 1993) using primers designed to
amplify a 570-bp fragment flanked by BamHI sites. BL-21
strain transformed with pGEX-2T-ASP was grown over-
night at 37°C in 2 ml of LB containing 100 mg/ml ampi-
cillin for further culture in 200 ml. After 5 h, induction was
performed with 1 mM IPTG for 15 h at room temperature.
Bacteria were centrifuged and the pellet was treated as
described by Frangioni and Neel (1993) with 1.5% sarko-
syl and 2% Triton X-100. Lysates were incubated with a
50% suspension of glutathione–agarose beads (Sigma)
for 30 min at 4°C. After six washes in PBS, pH 7.4,
proteins were eluted twice in 200 ml of 10 mM reduced
glutathione (Sigma). Proteins were subjected to electro-
phoresis in 10% SDS–PAGE (Laemmli, 1970) with
prestained protein molecular weight markers purchased
from Biolabs. Electrotransfer to PVDF filters was per-
formed in Tris–glycine ethanol buffer (Towbin et al., 1979)
and Western blot analysis was performed with anti-ASP,
anti-GST, and preimmune sera followed by incubation
with goat anti-rabbit peroxidase conjugate. Enzymatic
activity was detected by chemoluminescence using com-
mercially available materials (ECL kit, Amersham).
The pLXSN retroviral vector was used for stable ex-
pression of ASP tagged at its NH2 terminus with a pep-
tide containing the 15 COOH-terminal amino acids (497–
511) of vesicular stomatitis virus glycoprotein (VSV-G)
(Kreis, 1986). The tag sequence was inserted 59 to the
ASP sequence of the previously described pL(ASBRU)SN
vector (Tagieva and Vaquero, 1997). Briefly, the VSV-G
oligonucleotide, flanked with EcoRI and XhoI restriction
sites at the 59 and 39 ends, respectively, was ligated to
antisense HIV-1BRU ORF digested with BamHI. The fused
fragment was then inserted into the EcoRI/BamHI sites
of pLXSN, placing it under the transcriptional control of
183ASP IN HIV-1 INFECTED CELLS AND VIRAL PARTICLESthe Moloney MuSR LTR promoter (Miller and Rosman,
1989). After sequencing was performed, retroviral cCRIP
packaging cells (Danos and Mulligan, 1988) were trans-
fected with the pL(VSV-ASBRU)SN construct, as well as
with the pL(VSV)SN negative control vector, in order to
produce VSV–ASP expressing viruses used to infect
A3.01 T cells.
The pHXB2-MCS vector, the kind gift of N. Michael,
was used to transfect the SupT1 T cell line so as to
obtain cells productively infected with HIV-1HXB2 viruses
(McKeating et al., 1993).
Cells
Two lymphoid T cell lines infected with HIV-1 were
selected for study. These were the chronically infected
cell line ACH-2 provided by T. Folks (CDC, Atlanta), de-
rived by acute infection of A3.01 cells with HIV-1BRU (Folks
et al., 1985), and the SupT1HXB2 cell line, derived by
electroporation of SupT1 cells (the kind gift of V. Calvez)
with pHXB2-MCS vector. The A3.01 T cell line was trans-
duced with pL(VSV-ASBRU)SN so as to overexpress
tagged VSV–ASP or with pL(VSV)SN as a negative con-
trol (see below). The cells were designated A3.01 VSV–
ASP, and A3.01 VSV, respectively.
A3.01, A3.01 VSV–ASP, A3.01 VSV, ACH-2, and SupT1
cell lines were cultivated with 10% heat-inactivated fetal
calf serum, 100 IU/ml of penicillin, and 100 mg/ml of
streptomycin in RPMI 1640 Glutamax medium. Adherent
cCRIP cells were grown in Dulbecco’s modified Eagle’s
Glutamax medium, antibiotics, 10% heat-inactivated new-
born calf serum. All media and supplements were pur-
chased from Life Technologies. Transfection of cCRIP
packaging monolayer cells with the pL(VSV-ASBRU)SN or
pL(VSV)SN vectors was performed by the calcium phos-
phate precipitation method with glycerol treatment.
Transfected cCRIP cells were then selected with 0.5
mg/ml of G418 for 3 weeks. Infection of A3.01 lympho-
cytic cells was carried out by coculture for 48 h with
stable retroviral transformants as described in Tagieva
and Vaquero (1997). Neomycin-resistant cell populations
obtained 3 weeks later, after selection with 1 mg of
antibiotic/ml, were monitored for the presence of anti-
sense RNA by Northern blot. Total RNA was extracted
with commercially available materials (RNeasy kit, Qia-
gen) and 10 mg of sample was denatured with glyoxal,
subjected to electrophoresis in a 1% agarose gel, and
transferred to Hybond N filter (Pall) by SSC blotting.
VSV-AS RNA was detected using a specific sense ribo-
probe as described in Serpente et al. (1992).
ACH-2 cells, chronically infected with HIV-1BRU, pro-
duce few if any HIV-1 virions spontaneously. To induce
viral expression, the cells were activated with 50 nM
phorbol myristate acetate for 24 h (Serpente et al., 1992).
6SupT1 (5 3 10 ) cells were electroporated with 1 mg of
pHXB2-MCS DNA at 250 V/1500 mF and immediatelycentrifuged for 5 min at 1500 rpm. Following resuspen-
sion of electroporated cells in 0.5 ml of complete RPMI
medium, 5 3 106 of fresh cells were added in 9.5 ml
RPMI. Three to 5 days after transfection, cells exhibited
a cytopathic effect and began to produce virions.
Immunochemistry
Cells were fixed with 4% paraformaldehyde, 0.5% glu-
taraldehyde in cacodylate buffer (0.15 M sodium cacody-
late, pH 7.2), for 45 min at room temperature. After cen-
trifugation (3000g for 5 min) cells were washed three
times for 10 min in cacodylate buffer with 0.1 M NH4Cl.
After dehydration in a graded ethanol series (50–100%),
the material was embedded in LR WHITE resin (TAAB).
Ultrathin sections were transferred onto nickel EM
grids, which were floated on 20-ml drops of the different
reagents and solutions arrayed on a sheet of Parafilm for
postembedding labeling. Sections were incubated with
freshly prepared 0.1% NaBH4 for 10 min to inactivate
residual aldehyde groups, rinsed twice for 5 min in PBS,
pH 7.4, blocked with a commercially available solution
(Blocking Solution, Aurion) for 30 min, and then washed
33 for 5 min with a commercially available incubation
buffer (IB, Aurion), composed of 0.1% BSAc in PBS. Incu-
bation with primary anti-VSV (P5D4) or anti-ASP antibody
(0.5 to 5 mg/ml) was performed overnight at 4°C. After six
washes with IB, samples were incubated for 2 h at room
temperature with a 1:10 dilution of goat anti-mouse or
anti-rabbit IgG conjugated with 10-nm gold particles or
with a 1:100 dilution of goat anti-rabbit UltraSmall (US) or
F(ab9) goat anti-rabbit US, as the second antibody. Neg-
ative controls were either control cells before infection or
transfection incubated successively with the two anti-
bodies or cells potentially expressing ASP treated only
with the secondary gold-conjugated antibody. Grids were
extensively washed 63 5 min with IB and 33 for 5 min
with PBS, postfixed for 5 min with PBS/2% glutaralde-
hyde, rinsed with PBS, and finally rinsed with distilled
water. The US gold clusters were increased by a silver
enhancement reaction allowing detection at the EM level
(van de Plas and Leunissen, 1993). A freshly prepared
mixture of Developer and Enhancer solutions, both pur-
chased from Aurion, was applied to the specimens, as
recommended by the manufacturer, for 20 min at room
temperature. After uranyl acetate and lead citrate stain-
ing, specimens were examined with a Philips 201 trans-
mission electron microscope.
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